Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 22, 2020
TRI has been awarded a contract to conduct the Randomized Master Protocol for Immune Modulators for Treating COVID-19 study under BARDA in collaboration with the NIH.
read more
Wednesday, December 11, 2013
Trevigen Inc. has been awarded $252,000 for the Small Business Innovation Research (SBIR) Phase I Contract, 261201300042C, from the National Cancer Institute and the National Institutes of Health (NIH) to develop a tumor-aligned 3D coculture system. ...
read more
Tuesday, December 10, 2024
Matica Biotechnology has announced a strategic partnerships with Treovir that aims to advance innovative therapies for pediatric patients with brain and other neurological cancers. Matica Bio will provide GMP manufacturing for clinical supplies.
read more
The Trendlines Group has expanded its activities to Shanghai with the establishment of Trendlines Medical Shanghai Innovation Center, which has recently started operations.
read more
Trenchant BioSystems and Invetech have entered into a strategic alliance which will collaborate on the continued development of Trenchant’s fully automated AutoCell Platform, intended for future commercialization.
read more
Wednesday, August 15, 2018
Trellis Rx has hired Jerry Buller as Chief Pharmacy Officer and Brandon Newman as Vice President of Clinical Affairs.
read more
Friday, February 07, 2020
AGC Biologics and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114.
read more
Wednesday, January 19, 2022
Treadwell Therapeutics, a clinical stage, multi-modality biotechnology company developing novel therapeutics for highly aggressive cancers, and Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) have confirmed...
read more
Tuesday, February 18, 2014
Transposagen Biopharmaceuticals Inc. announced today that it has partnered with the Medical College of Wisconsin (MCW) to provide its gene editing tools for MCW’s recent grant from the National Heart, Lung, and Blood Institute to create new ...
read more
Transpire Bio has signed an agreement to expand the footprint of its R&D and Manufacturing capabilities in Pembroke Pines, Florida. The expansion is expected to enhance and build upon the company’s existing R&D and Commercial Manufacturing operations...
read more
Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has announced a definitive agreement with Recipharm to develop TRB-1 and TRB-2, inhaled medicines for the ...
read more
Friday, September 27, 2019
Translate Bio has entered into a multi-year strategic manufacturing agreement with AMRI in support of the planned expansion of Translate Bio’s cGMP clinical mRNA manufacturing capabilities.
read more
Powder containment and aseptic transfer valve specialist ChargePoint Technology is expanding its U.S. presence, following a multi-million-pound investment from LDC.
read more
TransCure bioServices partnered with Preclina to significantly expands TransCure’s reach into the APAC region, while also bolstering its service offerings to further enhance the quality of its research results.
read more
Transcenta announced its subsidiary has signed an exclusive agreement with Lilly to license a portfolio of novel biotherapeutics programs for development and commercialization in China.
read more